Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3417712
Max Phase: Preclinical
Molecular Formula: C13H16ClNO2
Molecular Weight: 253.73
Molecule Type: Small molecule
Associated Items:
ID: ALA3417712
Max Phase: Preclinical
Molecular Formula: C13H16ClNO2
Molecular Weight: 253.73
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: O=C(O)CN1CCCC1Cc1ccccc1Cl
Standard InChI: InChI=1S/C13H16ClNO2/c14-12-6-2-1-4-10(12)8-11-5-3-7-15(11)9-13(16)17/h1-2,4,6,11H,3,5,7-9H2,(H,16,17)
Standard InChI Key: PJDHKIBKWZGLMJ-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 253.73 | Molecular Weight (Monoisotopic): 253.0870 | AlogP: 2.43 | #Rotatable Bonds: 4 |
Polar Surface Area: 40.54 | Molecular Species: ZWITTERION | HBA: 2 | HBD: 1 |
#RO5 Violations: 0 | HBA (Lipinski): 3 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 1.59 | CX Basic pKa: 9.76 | CX LogP: 0.02 | CX LogD: 0.02 |
Aromatic Rings: 1 | Heavy Atoms: 17 | QED Weighted: 0.90 | Np Likeness Score: -1.13 |
1. Jurik A, Zdrazil B, Holy M, Stockner T, Sitte HH, Ecker GF.. (2015) A binding mode hypothesis of tiagabine confirms liothyronine effect on γ-aminobutyric acid transporter 1 (GAT1)., 58 (5): [PMID:25679268] [10.1021/jm5015428] |
Source(1):